The new CME article January 2018: “Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson’s disease” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All… Continue Reading

David B. Vodušek (DBV): When looking back at your long and varied career, can you tell us what was crucial for you to choose neurology as your specialty, and headache as your primary research field of interest?  Jes Olesen (JO): Already as a medical student, I was interested in neurology. I thought at that time – and I still think so today – that the brain is by far the most interesting organ in a human being.

Dear EAN members, dear readers, I would like to address you a few lines at the end of this year. For EANpages, the 2017 has marked the second year since the launch of the new format of the EAN news… Continue Reading

  The EAN Scientific Panel held its annual meeting on 25 June 2017 09:45 to 10:45 during the 3rd EAN Congress in Amsterdam. Chair of the meeting: Lueder Deecke, Management Group members present: Co-Chair Stefano Cappa, Pasquale Calabrese, Wolfgang Heide,… Continue Reading

David B Vodušek (DBV): In light of your long-standing experience in the world of neurology world-wide, what would your “diagnosis” be concerning its “state of art”? William Carroll (WC): What a good question to begin with. I would say my “diagnosis” is healthy and its prognosis is one of cautious optimism mixed with exciting opportunities and challenges.

The past year has been a good year for neurology. With the major progress for neurological treatments and the aging of the population, neurology is becoming one of the key disciplines of medicine. Its organized bodies like the World Federation of Neurology, the regional societies in America, Asia and Europe as well as the specialty societies for stroke, movement disorders, dementia, multiple sclerosis and many other diseases are becoming the key drivers of this development.

Abstract Submission Deadline for the Lisbon Congress  is only 6 weeks away.
Don’t miss you chance to be part of htis outstanidng event  in European Neurology.
You can find details and guidelines on how to submit an abstract on the… Continue Reading

      by Anna Sauerbier     The societal impact of pain (SIP) 2017 Steering Committee Meeting New techniques target protein clumps linked to Alzheimer’s and cancer Inside the solitary life of an Alzheimer’s sufferer E-health Tallinn 2017: i-prognosis… Continue Reading

The new CME article December 2017: “Characterization of isolated amyloid myopathy” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All e-learning activities are free-of-charge for EAN registered users.
Answer… Continue Reading

It is a great pleasure to introduce the recipients of the Research Fellowship 2018 (in alphabetical order):

Report from Dr Anca Adriana Arbune, from Bucharest, Romania visiting the Neurophysiology Department, Filadelfia Hospital, Dianalund, Denmark under the supervision of Prof. Sándor Beniczki.

The International Brain Tumour Alliance (IBTA) is a global network founded in 2005 as a worldwide community for brain tumour patient organisations, medical professionals  and others in the field of neuro oncology. We bring together international experience and expertise with the aim of enhancing the well-being and quality of life of brain tumour patients and their families and promoting the need for more brain tumour research.